With global travel restrictions, we are arranging online medical consultations with best medical centers as well as pre-bookings for future medical treatments. Explore Now… Go Later. Continue your healthcare journey.
Lung cancer is one of the most common causes of cancer death worldwide. Apart from Self-care, Medication (Chemotherapy and Targeted therapy), Surgery, Thoracotomy, Radiation therapy, and Palliative care, another factor that plays an important role in defending cancer is the Immunotherapy.
Immunotherapy is known to have a greater positive impact on the survival of a cancer patient. This is a biologic therapy that boosts the body's natural defenses to fight cancer. Immunotherapy uses substances produced by the body itself or prepared in a laboratory that improves or restore the immune functionality of the system. It stops or slows down the growth of cancer cells.
Cimavax is a cancer vaccine that represents a form of active immunotherapy, specifically in the treatment of non-small cell lung cancer (NSCLC). Developed in Cuba, the vaccine is a safe and immunogenic maintenance treatment implemented after chemotherapy, to help the primary lung cancer treatment succeed.
As a matter of fact, several forms of cancers, such as lung cancer, colon cancer or neck cancer grow and spread due to a protein called Epidermal Growth Factor (EGF) that stimulates cancer cells to mutate uncontrollably.
The prime function of Cimavax is to control the mutation of Epidermal Growth Factor Receptor (EGFR) by tumor cells that transform normal cells into cancer cells. It is made up of a human recombinant EGF that generates antibodies against the autologous EGF. These antibodies are major ligands to EGFR and reduce the concentrations of EGF in the blood. Thus, it immunizes the epidermal growth factor (EGF) in the patient. This results in EGF withdrawal and also lowers EGF-EGFR interaction in the cancer patient.
Cimavax is a relatively cheaper cancer vaccine both to produce and store. It also has low toxicity in comparison to other cancer therapies. Side effects of the Cimavax appear to be much mild in cancer patients. It may include chills, fever, or feeling sick.
In a nutshell, Cimavax controls the cancer cell inducement and does not target the cancer cells directly. Hence, it is considered to be a preventive vaccine in cancer treatment.
If you have further queries regarding how Cimavax works for lung cancer treatment, you can contact PlacidWay. We can even help you connect with the best of clinics offering lung cancer treatment using Cimavax in Cuba.